Skip to content

comparison of intravenous Dexamethasone and intravenous Dexmedetomidine for prevention of shivering in patients undergoing surgery under spinal anaesthesia.

A Prospective Randomized Controlled Trial Comparing the Efficacy of Intravenous Dexamethasone and Dexmedetomidine in Preventing Shivering after Sub Arachnoid Block. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092293
Enrollment
82
Registered
2025-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: IV Dexamethasone: Inj. Dexamethasone is available in a 2 ml (8 mg) vial. A 20 ml syringe will be loaded with 2 ml of the drug and diluted with normal saline to a total solution of 20 ml

Sponsors

AIIMS Deoghar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 to 60 years of either gender. 2. Patients of ASA physical status I and II. 3. Patients willing to participate. 4. Operative procedures requiring Spinal Anaesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients refusal to participate. 2. Patients with a known allergy to any of the study drugs, cardiac conduction defects, renal or hepatic impairment. 3. Any contraindications to spinal anesthesia. 4. Any contraindication to steroid therapy. 5. Parturients.

Design outcomes

Primary

MeasureTime frame
Assessing the Incidence of Shivering among the groupsTimepoint: Patients will be monitored for 60 minutes after administering the drug or till the end of the surgery, whichever will be longer,

Secondary

MeasureTime frame
Comparison of sedation score, nausea and vomiting among the groups.Timepoint: Patients will be monitored for 60 minutes after administering the drug or till the end of the surgery, whichever will be longer,;Comparison of hemodynamic variation, and rescue medications among the groups. Timepoint: Patients will be monitored for 60 minutes after administering the drug or till the end of the surgery, whichever will be longer,

Countries

India

Contacts

Public ContactDr Vikash Bansal

All India Institute of Medical Sciences, Deoghar

vikashbansal1990@gmail.com08588915101

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026